Atezolizumab Lung Toxicity: Importance of Combination Treatment On The Edge of Life, A Case Report

• Published in: Current drug safety Vol. 19; no. 4; p. 469
• Main Authors: Koc, Aysu Sinem, Can, Orcun, Kobak, Senol
• Format: Journal Article
• Language: English
• Published: United Arab Emirates 01.01.2024
• Subjects: Aged; Antibodies, Monoclonal, Humanized - adverse effects; Antibodies, Monoclonal, Humanized - therapeutic use; Carcinoma, Squamous Cell - drug therapy; Chemotherapy, Adjuvant; Humans; Immunoglobulins, Intravenous - therapeutic use; Lung Neoplasms - drug therapy; Male; Pneumonia - chemically induced; lung cancer; pneumonitis; IVIg; case report; mycophenolate mofetil; checkpoint inhibitors; Atezolizumab

Lung cancer is one of the most common and mortal cancers worldwide. According to pathological and clinical groups, treatments vary, and a tailored approach is considered. Adjuvant therapies, such as chemotherapy, radiation, and immune checkpoint inhibitors (ICI), are recommended by recent guidelines...